You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (i) Summary of distribution of age at first use (row percentage) for each primary drug type

Substance

<15

15-19

20-24

25-29

30-34

35-39

40-44

45+

Age known (base)

Age not known

Opiates

5.8

45.8

29.0

10.8

5.2

2.0

0.9

0.6

10263

9522

Cocaine

9.1

44.3

23.7

10.4

7.4

2.9

1.3

0.9

4319

4141

Stimulants

13.2

65.0

13.9

4.6

1.9

0.7

0.2

0.4

4744

1484

Hypnotics and sedatives

9.1

28.5

19.5

12.8

11.0

6.9

4.3

8.3

894

443

Hallucinogens

10.3

73.5

13.1

2.6

1.1

0.1

0.0

0.0

784

255

Volatile inhalants

29.5

65.8

2.5

3.0

0.0

0.0

0.0

0.0

237

69

Cannabis

36.8

54.8

5.8

1.6

0.6

0.3

0.1

0.1

10851

7820

Other substances

16.2

54.8

12.4

4.6

4.2

1.9

1.9

3.9

259

1319

 

 

 

 

 

 

 

 

 

 

 

Total

18.2

51.9

17.3

6.5

3.5

1.4

0.6

0.7

32351

25053

Notes:

Countries included: Denmark, Germany, Greece, Italy, Cyprus, Malta, Netherlands, Slovenia, Slovakia, Finland, Sweden, United Kingdom, Bulgaria.

The number of treatment clients in each country is listed in Table TDI-7.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source: 

2004 Reitox national reports - Table TDI outpatient treatment centres

Data filter | tditab11a-en.xml